news Cell-based assays market set to be worth $22bn by 2025 24 March 2021 | By Victoria Rees (Drug Target Review) New research has shown that the cell-based assays market will grow at a CAGR of 8.1 percent between 2020 and 2025.
news High-throughput screening market set to be worth $26.4bn by 2025 26 February 2021 | By Victoria Rees (Drug Target Review) According to a new report, the high-throughput screening market will increase at a CAGR of 11.5 percent from 2020 to 2025.
news AI in drug discovery market to increase at CAGR of 40.8 percent 20 November 2019 | By Victoria Rees (Drug Target Review) Research has found that artificial intelligence in drug discovery will be worth $1,434 million by the end of 2024.